Structure of the Stapled p53 Peptide Bound to Mdm2

被引:210
作者
Baek, Sohee [1 ,6 ]
Kutchukian, Peter S. [2 ]
Verdine, Gregory L. [2 ]
Huber, Robert [1 ,3 ,4 ,5 ]
Holak, Tad A. [1 ,7 ]
Lee, Ki Won [6 ]
Popowicz, Grzegorz M. [1 ]
机构
[1] Max Planck Inst Biochem, D-82152 Martinsried, Germany
[2] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA
[3] Tech Univ Munich, Dept Chem, D-85748 Garching, Germany
[4] Cardiff Univ, Sch Biosci, Cardiff CF10 3US, S Glam, Wales
[5] Univ Duisburg Essen, Ctr Med Biotechnol, D-45117 Essen, Germany
[6] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea
[7] Jagiellonian Univ, Fac Chem, PL-30060 Krakow, Poland
关键词
CANCER-THERAPY; BH3; HELIX; BINDING; REACTIVATION; INHIBITION; PATHWAY; DESIGN;
D O I
10.1021/ja2090367
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
Mdm2 is a major negative regulator of the tumor suppressor p53 protein, a protein that plays a crucial role in maintaining genome integrity. Inactivation of p53 is the most prevalent defect in human cancers. Inhibitors of the Mdm2-p53 interaction that restore the functional p53 constitute potential nongenotoxic anticancer agents with a novel mode of action. We present here a 2.0 angstrom resolution structure of the Mdm2 protein with a bound stapled p53 peptide. Such peptides, which are conformationally and proteolytically stabilized with all-hydrocarbon staples, are an emerging class of biologics that are capable of disrupting protein-protein interactions and thus have broad therapeutic potential. The structure represents the first crystal structure of an i, i + 7 stapled peptide bound to its target and reveals that rather than acting solely as a passive conformational brace, a staple can intimately interact with the surface of a protein and augment the binding interface.
引用
收藏
页码:103 / 106
页数:4
相关论文
共 27 条
[1]
Reactivation of the p53 tumor suppressor pathway by a stapled p53 peptide [J].
Bernal, Federico ;
Tyler, Andrew F. ;
Korsmeyer, Stanley J. ;
Walensky, Loren D. ;
Verdine, Gregory L. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (09) :2456-+
[2]
A Stapled p53 Helix Overcomes HDMX-Mediated Suppression of p53 [J].
Bernal, Federico ;
Wade, Mark ;
Godes, Marina ;
Davis, Tina N. ;
Whitehead, David G. ;
Kung, Andrew L. ;
Wahl, Geoffrey M. ;
Walensky, Loren D. .
CANCER CELL, 2010, 18 (05) :411-422
[3]
Reactivation of p53: from peptides to small molecules [J].
Brown, Christopher J. ;
Cheok, Chit F. ;
Verma, Chandra S. ;
Lane, David P. .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2011, 32 (01) :53-62
[4]
Awakening guardian angels: drugging the p53 pathway [J].
Brown, Christopher J. ;
Lain, Sonia ;
Verma, Chandra S. ;
Fersht, Alan R. ;
Lane, David P. .
NATURE REVIEWS CANCER, 2009, 9 (12) :862-873
[5]
ENTHALPY OF HYDROGEN-BOND FORMATION IN A PROTEIN-LIGAND BINDING REACTION [J].
CONNELLY, PR ;
ALDAPE, RA ;
BRUZZESE, FJ ;
CHAMBERS, SP ;
FITZGIBBON, MJ ;
FLEMING, MA ;
ITOH, S ;
LIVINGSTON, DJ ;
NAVIA, MA ;
THOMSON, JA ;
WILSON, KP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (05) :1964-1968
[6]
High affinity interaction of the p53 peptide-analogue with human Mdm2 and Mdmx [J].
Czarna, Anna ;
Popowicz, Grzegorz M. ;
Pecak, Aleksandra ;
Wolf, Siglinde ;
Dubin, Grzegorz ;
Holak, Tad A. .
CELL CYCLE, 2009, 8 (08) :1176-1184
[7]
THE ENTROPIC COST OF BOUND WATER IN CRYSTALS AND BIOMOLECULES [J].
DUNITZ, JD .
SCIENCE, 1994, 264 (5159) :670-670
[8]
Stapled peptides in the p53 pathway Computer simulations reveal novel interactions of the staples with the target protein [J].
Joseph, Thomas Leonard ;
Lane, David ;
Verma, Chandra .
CELL CYCLE, 2010, 9 (22) :4560-4568
[9]
Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain [J].
Kussie, PH ;
Gorina, S ;
Marechal, V ;
Elenbaas, B ;
Moreau, J ;
Levine, AJ ;
Pavletich, NP .
SCIENCE, 1996, 274 (5289) :948-953
[10]
All-Atom Model for Stabilization of α-Helical Structure in Peptides by Hydrocarbon Staples [J].
Kutchukian, Peter S. ;
Yang, Jae Shick ;
Verdine, Gregory L. ;
Shakhnovich, Eugene I. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2009, 131 (13) :4622-4627